This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Gastrointestinal Diseases  • Alert me on articles by topic

JAMA. 2008;299(1):88.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In a Clinical Crossroads article published in February 2006,¹ Anthony Lembo, MD, discussed the symptoms, diagnostic considerations, and treatment options relating to irritable bowel syndrome (IBS). Mrs G had a long history of abdominal pain, bloating, and discomfort associated with constipation, which worsened in the years preceding her diagnosis. A small woman, Mrs G was trying to gain weight as a measure to combat her recently diagnosed osteopenia and was particularly concerned that her symptoms prevented her from gaining weight. After watching a television advertisement for a new prescription medication, Mrs G finally discussed her symptoms with her physician, who diagnosed constipation-predominant IBS (IBS-C) . Mrs G began a trial of tegaserod, which helped her symptoms significantly, although she was reluctant to take medication regularly. Mrs G wondered about the efficacy of tegaserod as a long-term solution to her condition. She also wondered whether there would be long-term adverse effects . . . [Full Text of this Article]

MRS G

Nadine Farag, BS; Eileen Reynolds, MD; Anthony Lembo, MD